PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 14 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,713,000 | -37.7% | 3,000,000 | -40.0% | 0.01% | -46.7% |
| Q4 2020 | $4,353,000 | -18.5% | 5,000,000 | -23.1% | 0.02% | -44.4% |
| Q3 2020 | $5,343,000 | +0.6% | 6,500,000 | 0.0% | 0.03% | -22.9% |
| Q2 2020 | $5,309,000 | +4.9% | 6,500,000 | 0.0% | 0.04% | -56.8% |
| Q1 2020 | $5,062,000 | +7.8% | 6,500,000 | 0.0% | 0.08% | +224.0% |
| Q4 2019 | $4,696,000 | -10.8% | 6,500,000 | -9.5% | 0.02% | -30.6% |
| Q3 2019 | $5,264,000 | +7.4% | 7,182,000 | 0.0% | 0.04% | +2.9% |
| Q2 2019 | $4,902,000 | – | 7,182,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $22,462,000 | 6.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 29,590,000 | $23,376,000 | 1.99% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,750,000 | $22,339,000,000 | 0.49% |
| AQR Arbitrage LLC | 3,050,000 | $2,491,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,950,000 | $3,197,000 | 0.10% |
| Teton Advisors, Inc. | 400,000 | $323,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,500,000 | $5,309,000 | 0.04% |
| MACQUARIE GROUP LTD | 11,329,000 | $5,922,000 | 0.01% |
| GABELLI FUNDS LLC | 750,000 | $606,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 4,000,000 | $3,184,000 | 0.00% |